Polaryx Therapeutics Common Stock Overview
Polaryx Therapeutics Common Stock Discounted Cash Flow
DCF Analysis for PLYX.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.11
Current Fair Value
$0.11
↓ 95.3% Downside
Overvalued by 95.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison